Executive Team


MD, PhD, Co-Founder
and CEO

Dr. Kris Siemionow is a board certified orthopaedic surgeon and an entrepreneur, who founded and co-founded multiple medical companies, that utilize advanced technology to improve clinical outcomes. Dr. Siemionow completed residency at the Cleveland Clinic Foundation in orthopedic surgery and a spine surgery fellowship at Rush University Medical Center. His PhD focused on the effects of inflammation on nerve cell function. Dr. Siemionow is co-founder of Global Spine Outreach a non-for profit organization whose mission is to “save children with severe spinal deformities”.

Dr. Siemionow co-founded Holo Surgical Inc, a digital surgery company that developed an artificial intelligence-based surgical guidance system, which is currently in clinical use. He also co-founded Inteneural Networks Inc, a company that utilizes machine learning to diagnose neurodegenerative disorders. Dr. Siemionow co-founded Kardiolytics Inc, a company that utilizes machine learning to perform a virtual coronary stress test.

Dr. Siemionow has authored over 100 peer reviewed articles, abstracts, and book chapters pertaining to surgery and basic science research. He holds 25 patents and patent applications, which have been successfully commercialized.


PhD, Co-Founder
and Board Member

Dr. Lewicki is a cognitive scientist, an entrepreneur, and investor. He was a professor of cognitive psychology at the University of Tulsa from 1984 through 2009, where he established the Nonconscious Information Processing Laboratory, using multiple research grants from the National Science Foundation and National Institutes of Health.

Dr. Lewicki was among the first to publish evidence that the advanced expertise acquired by humans from experience, involves multivariate and highly-interactive patterns in data, which are much more complex than what humans are able to consciously articulate or even communicate. This approach became popular and quickly adopted by the corporate world as so-called “predictive data mining” – making computers derive from Big Data more complex patterns than humans can understand and then use these patterns to make new predictions. Dr. Lewicki started StatSoft, a company that pioneered commercial applications of data mining. StatSoft rapidly became a large developer of data mining solutions for all industries with offices in 30 countries, and over 1 million accounts, where he was a CEO and the main shareholder. StatSoft was sold to Dell in 2014.

As a cognitive scientist, Dr. Lewicki continues to develop artificial intelligence (AI) technologies that make computers smarter. As a businessman, Dr. Lewicki invests in (and helps develop) companies that strive to “make a difference” by using AI to promote the general welfare by accelerating technological progress, especially in the area of medicine, that has been traditionally slower in adopting artificial intelligence.


Vice President of
Business Development
and Investor Relations

Marta is an entrepreneur, was involved in technology transfer for over 10 years, and she co-founded and managed multiple start-ups. During her career, Marta has participated in many transactions including financing and licensing of early-stage projects.

She worked at the Medical University in Warsaw, where she served as a mentor in business development and financing strategies. She was responsible for creating investment opportunities, raising capital, and leading commercialization initiatives.

Marta has also extensive experience working with VC funds. She led the due diligence processes and supported investors in deal flow management. Marta acted as advisor in the area of business development to boards of several companies.